Buprenorphine Extended-Release Injection and Paclitaxel Novaplus
Determining the interaction of Buprenorphine Extended-Release Injection and Paclitaxel Novaplus and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: paclitaxel
Brand name: Onxol, Taxol
Synonyms: Paclitaxel, PACLitaxel (Conventional)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine Extended-Release Injection-Paclitaxel protein-bound
- Buprenorphine Extended-Release Injection-Paclitaxel protein-bound Intravenous
- Buprenorphine Extended-Release Injection-Pacnex
- Buprenorphine Extended-Release Injection-Pacnex LP
- Buprenorphine Extended-Release Injection-Pacnex MX
- Buprenorphine Extended-Release Injection-Pain Enz Topical
- Paclitaxel Novaplus-Buprenorphine implant
- Paclitaxel Novaplus-Buprenorphine Injection
- Paclitaxel Novaplus-Buprenorphine injection - Buprenex
- Paclitaxel Novaplus-Buprenorphine injection - Sublocade
- Paclitaxel Novaplus-Buprenorphine Intradermal
- Paclitaxel Novaplus-Buprenorphine oral/buccal